Survey on medication information leaflets for organ transplant patients
Development and Validation of Materials for the Pharmaceutical Care of Organ Transplant Recipients in Community Pharmacy: Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients
This study is trying to find out what organ transplant patients and their caregivers think about the medication information leaflets to make them clearer and more helpful.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universität Münster Academic / other |
| Locations | 1 site (Münster, North Rhine-Westphalia) |
| Trial ID | NCT06652919 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather feedback from organ transplant patients and their caregivers regarding the medication information leaflets developed for them. Using a questionnaire, the study will assess the effectiveness and clarity of these leaflets to ensure they meet the specific needs of this patient population. The feedback will be used to refine the content of the leaflets, enhancing patient understanding and adherence to their medication regimens. The study highlights the importance of tailored pharmaceutical care for organ transplant recipients.
Who should consider this trial
Good fit: Ideal candidates include adult organ transplant patients or their caregivers who are German-speaking and currently taking immunosuppressants.
Not a fit: Patients who are not able to provide consent, non-German speakers, those under 18 years old, or individuals who have undergone transplantation but are no longer taking immunosuppressants may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve patient understanding and adherence to medication regimens, leading to better health outcomes for organ transplant recipients.
How similar studies have performed: While this approach is focused on patient feedback for medication leaflets, similar studies have shown that tailored information can significantly enhance patient adherence and safety in medication management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have undergone solid organ transplantation (kidney, liver, heart, lung) * Caregivers or family members of organ transplant patients * German-speaking individuals * adult Exclusion Criteria: * Individuals who are not able to provide consent * Non-German-speaking individuals * under 18 years old * Patients who have undergone organ transplantation and are no longer taking immunosuppressants
Where this trial is running
Münster, North Rhine-Westphalia
- Institute of Pharmaceutical and Medicinal Chemistry, Clinical Pharmacy, University of Münster — Münster, North Rhine-Westphalia, Germany (Recruiting)
Study contacts
- Study coordinator: Li-Yun Chen
- Email: liyun.chen@uni-muenster.de
- Phone: +49 (0) 251 83-32173
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.